These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23259666)

  • 1. Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface.
    Choi SK; Myc A; Silpe JE; Sumit M; Wong PT; McCarthy K; Desai AM; Thomas TP; Kotlyar A; Holl MM; Orr BG; Baker JR
    ACS Nano; 2013 Jan; 7(1):214-28. PubMed ID: 23259666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the Adhesion Forces for the Multivalent Binding of Vancomycin-Conjugated Dendrimer to Bacterial Cell-Wall Peptide.
    Peterson E; Joseph C; Peterson H; Bouwman R; Tang S; Cannon J; Sinniah K; Choi SK
    Langmuir; 2018 Jun; 34(24):7135-7146. PubMed ID: 29792710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria.
    Kell AJ; Stewart G; Ryan S; Peytavi R; Boissinot M; Huletsky A; Bergeron MG; Simard B
    ACS Nano; 2008 Sep; 2(9):1777-88. PubMed ID: 19206416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of high-affinity peptide ligands for vancomycin.
    Yao N; Wu CY; Xiao W; Lam KS
    Biopolymers; 2008; 90(3):421-32. PubMed ID: 18260149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via Its Bivalent Motifs of Interaction.
    Bowden S; Joseph C; Tang S; Cannon J; Francis E; Zhou M; Baker JR; Choi SK
    Biochemistry; 2018 May; 57(18):2723-2732. PubMed ID: 29651842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
    Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS
    Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent dendrimer vectors with DNA intercalation motifs for gene delivery.
    Wong PT; Tang K; Coulter A; Tang S; Baker JR; Choi SK
    Biomacromolecules; 2014 Nov; 15(11):4134-45. PubMed ID: 25285357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMAM-dendrimer Enhanced Antibacterial Effect of Vancomycin Hydrochloride Against Gram-Negative Bacteria.
    Serri A; Mahboubi A; Zarghi A; Moghimi HR
    J Pharm Pharm Sci; 2018; 22(1):10-21. PubMed ID: 30589641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies.
    Sonawane SJ; Kalhapure RS; Rambharose S; Mocktar C; Vepuri SB; Soliman M; Govender T
    Int J Pharm; 2016 May; 504(1-2):1-10. PubMed ID: 26992817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
    Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
    ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
    Nitanai Y; Kikuchi T; Kakoi K; Hanamaki S; Fujisawa I; Aoki K
    J Mol Biol; 2009 Feb; 385(5):1422-32. PubMed ID: 18976660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-modified LaB6@SiO2/Fe3O4 composite nanoparticles for near-infrared photothermal ablation of bacteria.
    Lai BH; Chen DH
    Acta Biomater; 2013 Jul; 9(7):7573-9. PubMed ID: 23535232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
    Lee JG; Sagui C; Roland C
    J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens.
    Kavruk M; Celikbicak O; Ozalp VC; Borsa BA; Hernandez FJ; Bayramoglu G; Salih B; Arica MY
    Chem Commun (Camb); 2015 May; 51(40):8492-5. PubMed ID: 25891472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
    Qi G; Li L; Yu F; Wang H
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
    Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
    Hong S; Leroueil PR; Majoros IJ; Orr BG; Baker JR; Banaszak Holl MM
    Chem Biol; 2007 Jan; 14(1):107-15. PubMed ID: 17254956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.